Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Frontiers in Oncology|February 17, 2023
Lipid profile as a novel prognostic predictor for patients with acute myeloid leukemiaShenrui Bai, Huizhong Wang, Ruonan Shao, et al.Cancer Cell International|May 15, 2022
Integrative analysis identifies CXCL11 as an immune-related prognostic biomarker correlated with cell proliferation and immune infiltration in multiple myeloma microenvironmentHuizhong Wang, Ruonan Shao, Wenjian Liu, et al.Cancers|October 16, 2025
Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs)Xinyu Ma, Zhibo Zhou, Shuyu Gu, et al.Scientific Reports|January 24, 2025
Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levelsRuonan Shao, Danchen Meng, Beibei Gao, et al.Biomarker Research|June 17, 2023
Biomarkers as targets for CAR-T/NK cell therapy in AMLRuonan Shao, Zijian Li, Honglei Xin, et al.Medcomm|May 13, 2024
Interleukin-33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species-mediated inhibition of nuclear factor kappa-B signal and stemness propertiesRuonan Shao, Shuang Liu, Wenjian Liu, et al.International Journal of Biological Sciences|January 22, 2024
Tumor-derived Exosomal ENO2 Modulates Polarization of Tumor-associated Macrophages through Reprogramming Glycolysis to Promote Progression of Diffuse Large B-cell LymphomaRuonan Shao, Chengcheng Liu, Ruifeng Xue, et al.Biomolecules|February 26, 2025
Paxillin and Kindlin: Research Progress and Biological FunctionsZijian Li, Ruonan Shao, Honglei Xin, et al.Journal of Translational Internal Medicine|October 31, 2025
Comprehensive investigation of cuproptosis-related genes in clinical features, biological characteristics, and immune microenvironment in B-cell Non-Hodgkin lymphomaChengcheng Liu, Ruonan Shao, Xiaoqing Li, et al.Journal for Immunotherapy of Cancer|September 22, 2025
Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinomaShuang Liu, Yihui Pan, Wenjian Liu, et al.Pageof 3